Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)Matthew M.Y. Lee, Naveed Sattar, Katriona Brooksbank et al.|Circulation|2020Cited by 437
Aficamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMartin S. Maron, Theodore P. Abraham, Brian Claggett et al.|New England Journal of Medicine|2024Cited by 277
Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary SyndromeMatthew M.Y. Lee, Mark C. Petrie, Paul Rocchiccioli et al.|Circulation Cardiovascular Interventions|2019Cited by 31
Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populationsMatthew M.Y. Lee, Colin Berry, Paul Rocchiccioli et al.|Open Heart|2021Cited by 5